Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal Sinus
Public ClinicalTrials.gov record NCT02266810. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The PROGRESS Study: Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implants Following Surgical Opening of the Frontal Sinus for Chronic Sinusitis: A Randomized Blinded Controlled Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the PROGRESS Study is to assess the safety and efficacy of the Propel Mini and Propel Nova steroid-eluting Sinus Implants when placed in the frontal sinus opening following frontal sinus surgery in patients with chronic sinusitis.
Study identification
- NCT ID
- NCT02266810
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Interventions
- PROPEL Mini Sinus Implant. Device
- Sinus Surgery alone Procedure
- Propel Nova Sinus Implant Device
Device · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2014 (Type not available)
- Primary completion
- Apr 2016 (Actual)
- Completion
- Oct 2016 (Actual)
- Last update posted
- Aug 15, 2018
2014 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sacramento Ear, Nose and Throat | Sacramento | California | 95815 | — |
| Breathe Clear Institute of Sinus and Allergy Relief | Torrance | California | 90503 | — |
| The Connecticut Center for Advanced ENT Care | Norwalk | Connecticut | 06851 | — |
| George Washington University Medical Faculty Associates | Washington D.C. | District of Columbia | 20006 | — |
| ENT of Georgia | Atlanta | Georgia | 30342 | — |
| Advanced ENT and Allergy | Louisville | Kentucky | 40207 | — |
| Albany ENT and Allergy | Albany | New York | 12206 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| East Virginia Medical School | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02266810, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02266810 live on ClinicalTrials.gov.